- Home
- RVPH vs MGLD Comparison
RVPH vs MGLD Comparison
Compare RVPH & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- MGLD
- Stock Information
- Founded
- RVPH 2006
- MGLD 1996
- Country
- RVPH United States
- MGLD United States
- Employees
- RVPH N/A
- MGLD N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- MGLD Finance/Investors Services
- Sector
- RVPH Health Care
- MGLD Finance
- Exchange
- RVPH Nasdaq
- MGLD Nasdaq
- Market Cap
- RVPH 50.0M
- MGLD 59.9M
- IPO Year
- RVPH N/A
- MGLD N/A
- Fundamental
- Price
- RVPH $1.78
- MGLD $1.65
- Analyst Decision
- RVPH Strong Buy
- MGLD
- Analyst Count
- RVPH 4
- MGLD 0
- Target Price
- RVPH $15.33
- MGLD N/A
- AVG Volume (30 Days)
- RVPH 5.1M
- MGLD 13.8K
- Earning Date
- RVPH 11-14-2024
- MGLD 02-12-2025
- Dividend Yield
- RVPH N/A
- MGLD N/A
- EPS Growth
- RVPH N/A
- MGLD N/A
- EPS
- RVPH N/A
- MGLD N/A
- Revenue
- RVPH N/A
- MGLD $32,511,000.00
- Revenue This Year
- RVPH N/A
- MGLD N/A
- Revenue Next Year
- RVPH N/A
- MGLD N/A
- P/E Ratio
- RVPH N/A
- MGLD N/A
- Revenue Growth
- RVPH N/A
- MGLD N/A
- 52 Week Low
- RVPH $0.60
- MGLD $0.78
- 52 Week High
- RVPH $5.67
- MGLD $2.10
- Technical
- Relative Strength Index (RSI)
- RVPH 53.02
- MGLD 54.95
- Support Level
- RVPH $1.23
- MGLD $1.32
- Resistance Level
- RVPH $1.75
- MGLD $2.10
- Average True Range (ATR)
- RVPH 0.53
- MGLD 0.20
- MACD
- RVPH -0.07
- MGLD 0.03
- Stochastic Oscillator
- RVPH 18.57
- MGLD 48.28
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.